Clinical Trial Update: Skin Biopsy Specimens as Biomarkers of Systemic Sclerosis and Response to Mycophenolate Mofetil

View source ↗

Summary

This completed clinical trial investigated skin biopsy biomarkers in systemic sclerosis and their relation to response to mycophenolate mofetil.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Systemic Sclerosis | Status: COMPLETED